echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Is it okay if your blood sugar rises slightly? "Prediabetes" can also lead to vision impairment!

    Is it okay if your blood sugar rises slightly? "Prediabetes" can also lead to vision impairment!

    • Last Update: 2023-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Yimaitong compiles and arranges, please do not reprint
    without authorization.

     

    Retinal microangiopathy (DR) is a classic diabetes-related complication that can lead to vision loss
    in severe cases.
    The study found that DR can also occur in "pre-diabetic" people, and glycosylated hemoglobin (HbA1c) is an important risk factor (a 0.
    7% increase in HbA1c increases the risk of DR by 92%)
    .
    The findings were published in thejournal
    Diabetes Care.

     

     

    During the Diabetes Prevention Program (DPP) and DPP Outcome Study (DPPOS), fundus photography
    was performed on adults at high risk of T2D, including those who already had diabetes.
    Fundus photographs were graded using the ETDRS grading system, which defined as typical lesions (microaneurysm, exudation, bleeding, or more severe manifestations)
    in any eye.

     

    "Slightly elevated blood glucose" should also be a concern, and DR may also occur in prediabetes

     

    By DPPOS year 16, 24% of 1614 T2D subjects and 14% of 885 non-diabetic subjects developed DR.

     

    In univariate analysis, American Indian populations had significantly lower
    DR events compared to non-Hispanic whites (NHWs).
    Higher blood glucose levels (HbA1c, fasting, OGTT 2-hour blood glucose), greater body weight, history of hypertension, dyslipidemia, and smoking are associated with
    more frequent DR events.

     

    Multivariate analysis showed that the US Indian population had significantly fewer DR events compared with NHW (OR 0.
    36, 95% CI 0.
    20-0.
    66), higher mean HbA1c levels were significantly associated with more DR events (OR 1.
    92, 95% CI 1.
    46-1.
    74), and a 92% increase in DR risk for every 0.
    7%
    increase in HbA1c.

     

    Table 1 Indian population and mean HbA1c level are important risk factors for DR

     

    Summary of this article

     

    After more than ten years of follow-up, it has been found that type 2 diabetes and pre-diabetic people with slightly elevated blood sugar may develop DR, HbA1c is an important risk factor, and the risk of DR increases by 92% for every 0.
    7% increase in HbA1c, suggesting clinical attention
    .

     

    Compiled by Neil H.
    White, Qing Pan, William C.
    Knowler, et al.
    Diabetes Prevention Program Outcome Study (DPPOS) Research Group:; Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience.
    Diabetes Care 1 November 2022; 45 (11): 2653–2661.
    https://doi.
    org/10.
    2337/dc22-0860

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.